Top Page
Life Healthcare Group
(0928)
Life Healthcare Group (0928) vs. iShares MSCI Hong Kong ETF (EWH)
Life Healthcare Group Business Overview & Revenue Model
Life Healthcare Group Financial Statement Overview
| Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 233.68M | 223.85M | 92.87M | 102.04M | 63.80M |
| Gross Profit | 37.79M | 12.05M | 13.75M | 26.23M | 10.01M |
| EBITDA | 27.69M | -26.72M | -29.18M | 9.68M | -17.55M |
| Net Income | 15.82M | -25.19M | -34.46M | -4.58M | -24.85M |
Balance Sheet | |||||
| Total Assets | 336.13M | 264.27M | 302.94M | 325.01M | 303.95M |
| Cash, Cash Equivalents and Short-Term Investments | 473.00K | 17.79M | 37.40M | 8.57M | 187.58M |
| Total Debt | 5.71M | 6.73M | 422.00K | 715.00K | 1.88M |
| Total Liabilities | 70.08M | 31.27M | 39.56M | 30.32M | 54.41M |
| Stockholders Equity | 269.85M | 237.50M | 262.28M | 290.58M | 247.43M |
Cash Flow | |||||
| Free Cash Flow | -32.32M | -134.69M | 96.85M | -181.34M | 173.59M |
| Operating Cash Flow | -32.32M | -134.48M | 96.86M | -181.34M | 173.59M |
| Investing Cash Flow | 1.00K | 94.86M | -67.83M | -34.46M | 5.00K |
| Financing Cash Flow | 17.39M | 27.40M | -830.00K | 28.29M | -1.91M |
Life Healthcare Group Technical Analysis
Life Healthcare Group Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | HK$217.33M | 9.09 | 10.72% | 4.46% | -22.12% | -28.95% | |
60 Neutral | HK$17.07B | 5.63 | -7.44% | 2.87% | 11.55% | -28.15% | |
58 Neutral | HK$173.94M | 12.21 | 4.95% | ― | -25.28% | ― | |
51 Neutral | HK$146.55M | ― | -18.22% | ― | -56.16% | 62.50% | |
42 Neutral | HK$172.08M | ― | -305.54% | ― | -35.16% | -37.27% | |
| ― | ― | ― | ― | ― | |||
| ― | €19.44M | ― | -18.59% | ― | ― | ― |
Life Healthcare Group Corporate Events
King International Investment Limited, formerly known as Life Healthcare Group Limited, is dealing with a legal dispute involving a winding-up petition filed by Mianyang Zhongshang Fule Wine Co., Ltd. The dispute centers around a sale of goods agreement for Kunsha Aged Liquor, with allegations against former directors for unauthorized agreements. The company is questioning the validity of these agreements and is seeking legal advice to address potential financial losses.
King International Investment Limited has entered into a strategic cooperation framework agreement with Mingyuan Business School Co., Ltd. to enhance the marketing and operation of its liquor and healthcare products in Mainland China. This collaboration aims to leverage Mingyuan’s marketing expertise to improve market penetration and brand value, creating mutual benefits and synergies for both parties over a three-year term.
King International Investment Limited, formerly known as Life Healthcare Group Limited, is addressing potential allegations against a former executive director and a non-executive director related to unauthorized agreements and transactions. The company has implemented remedial measures, including seeking legal advice and suspending the non-executive director, to mitigate any potential impact on its operations and financial position. Despite the petition for winding up being withdrawn, the company is taking steps to ensure compliance and protect its interests.
King International Investment Limited, formerly known as Life Healthcare Group Limited, has announced the composition of its board of directors effective from April 24, 2025. The board includes executive, non-executive, and independent non-executive directors, with Mr. Leng Yueyingtan serving as Chairman. The company has also established four board committees: Audit, Nomination, Remuneration, and Fund Management, with specific directors assigned to each committee.
King International Investment Limited, formerly known as Life Healthcare Group Limited, announced the resignation of Ms. Yang Xilin as an independent non-executive director and chairman of several board committees, effective April 10, 2025. This resignation has led to non-compliance with certain listing rules, as the company no longer meets the required qualifications and committee compositions. The company plans to fill the vacancy within three months and has appointed Mr. Liu Zhong as the new chairman of the Remuneration Committee.
King International Investment Limited, formerly known as Life Healthcare Group Limited, has announced changes to its board of directors effective April 10, 2025. The company has appointed Mr. Leng Yueyingtan as Chairman and has restructured its board committees, which include the Audit, Nomination, Remuneration, and Fund Management Committees. These changes reflect a strategic move to enhance governance and operational oversight, potentially impacting the company’s market positioning and stakeholder engagement.
King International Investment Limited, formerly known as Life Healthcare Group Limited, announced the withdrawal of a winding-up petition filed by Mianyang Zhongshang Fule Wine Co., Ltd. The Hong Kong High Court granted leave for the petitioner to withdraw the petition, and the company plans to conduct an audit and due diligence on the disputed transaction. The company will keep shareholders and potential investors informed of any developments.
King International Investment Limited, formerly known as Life Healthcare Group Limited, has announced an extraordinary general meeting to be held on 7 March 2025, where shareholders will vote on proposed amendments to the company’s Articles of Association. The board seeks approval for the adoption of a revised set of articles, which consolidates previous amendments, to streamline the company’s governance framework.